vs
Apellis Pharmaceuticals, Inc.（APLS）与OXFORD INDUSTRIES INC（OXM）财务数据对比。点击上方公司名可切换其他公司
OXFORD INDUSTRIES INC的季度营收约是Apellis Pharmaceuticals, Inc.的1.5倍（$307.3M vs $199.9M），OXFORD INDUSTRIES INC净利率更高（-20.7% vs -29.5%，领先8.8%），OXFORD INDUSTRIES INC同比增速更快（-0.2% vs -5.9%），Apellis Pharmaceuticals, Inc.自由现金流更多（$-14.3M vs $-47.9M），过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高（7.7% vs -3.0%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
牛津工业公司是美国一家上市服装企业，主打高端服装及服饰产品，旗下拥有多个知名品牌，包括汤米·巴哈马、莉莉·普利策、强尼·瓦斯和萨瑟恩泰德等。
APLS vs OXM — 直观对比
营收规模更大
OXM
是对方的1.5倍
$199.9M
营收增速更快
OXM
高出5.7%
-5.9%
净利率更高
OXM
高出8.8%
-29.5%
自由现金流更多
APLS
多$33.6M
$-47.9M
两年增速更快
APLS
近两年复合增速
-3.0%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $307.3M |
| 净利润 | $-59.0M | $-63.7M |
| 毛利率 | — | 60.3% |
| 营业利润率 | -25.6% | -27.7% |
| 净利率 | -29.5% | -20.7% |
| 营收同比 | -5.9% | -0.2% |
| 净利润同比 | -62.2% | -1517.6% |
| 每股收益（稀释后） | $-0.40 | $-4.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSOXM
| Q4 25 | $199.9M | $307.3M | ||
| Q3 25 | $458.6M | $403.1M | ||
| Q2 25 | $178.5M | $392.9M | ||
| Q1 25 | $166.8M | — | ||
| Q4 24 | $212.5M | $308.0M | ||
| Q3 24 | $196.8M | $419.9M | ||
| Q2 24 | $199.7M | $398.2M | ||
| Q1 24 | $172.3M | $404.4M |
净利润APLSOXM
| Q4 25 | $-59.0M | $-63.7M | ||
| Q3 25 | $215.7M | $16.7M | ||
| Q2 25 | $-42.2M | $26.2M | ||
| Q1 25 | $-92.2M | — | ||
| Q4 24 | $-36.4M | $-3.9M | ||
| Q3 24 | $-57.4M | $40.6M | ||
| Q2 24 | $-37.7M | $38.4M | ||
| Q1 24 | $-66.4M | $-60.1M |
毛利率APLSOXM
| Q4 25 | — | 60.3% | ||
| Q3 25 | — | 61.4% | ||
| Q2 25 | — | 64.2% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 63.1% | ||
| Q3 24 | — | 63.1% | ||
| Q2 24 | — | 64.9% | ||
| Q1 24 | — | 60.9% |
营业利润率APLSOXM
| Q4 25 | -25.6% | -27.7% | ||
| Q3 25 | 48.7% | 6.3% | ||
| Q2 25 | -18.6% | 9.2% | ||
| Q1 25 | -50.0% | — | ||
| Q4 24 | -12.3% | -2.0% | ||
| Q3 24 | -24.0% | 12.5% | ||
| Q2 24 | -14.7% | 13.2% | ||
| Q1 24 | -36.0% | -20.1% |
净利率APLSOXM
| Q4 25 | -29.5% | -20.7% | ||
| Q3 25 | 47.0% | 4.1% | ||
| Q2 25 | -23.6% | 6.7% | ||
| Q1 25 | -55.3% | — | ||
| Q4 24 | -17.1% | -1.3% | ||
| Q3 24 | -29.2% | 9.7% | ||
| Q2 24 | -18.9% | 9.6% | ||
| Q1 24 | -38.5% | -14.9% |
每股收益（稀释后）APLSOXM
| Q4 25 | $-0.40 | $-4.28 | ||
| Q3 25 | $1.67 | $1.12 | ||
| Q2 25 | $-0.33 | $1.70 | ||
| Q1 25 | $-0.74 | — | ||
| Q4 24 | $-0.30 | $-0.25 | ||
| Q3 24 | $-0.46 | $2.57 | ||
| Q2 24 | $-0.30 | $2.42 | ||
| Q1 24 | $-0.54 | $-3.72 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $8.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $370.1M | $528.0M |
| 总资产 | $1.1B | $1.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资APLSOXM
| Q4 25 | $466.2M | $8.0M | ||
| Q3 25 | $479.2M | $6.9M | ||
| Q2 25 | $370.0M | $8.2M | ||
| Q1 25 | $358.4M | — | ||
| Q4 24 | $411.3M | $7.0M | ||
| Q3 24 | $396.9M | $18.4M | ||
| Q2 24 | $360.1M | $7.7M | ||
| Q1 24 | $325.9M | $7.6M |
总债务APLSOXM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $93.1M | $29.0M |
股东权益APLSOXM
| Q4 25 | $370.1M | $528.0M | ||
| Q3 25 | $401.2M | $597.1M | ||
| Q2 25 | $156.3M | $592.4M | ||
| Q1 25 | $164.2M | — | ||
| Q4 24 | $228.5M | $612.2M | ||
| Q3 24 | $237.1M | $621.6M | ||
| Q2 24 | $264.3M | $592.9M | ||
| Q1 24 | $266.7M | $560.9M |
总资产APLSOXM
| Q4 25 | $1.1B | $1.3B | ||
| Q3 25 | $1.1B | $1.3B | ||
| Q2 25 | $821.4M | $1.3B | ||
| Q1 25 | $807.3M | — | ||
| Q4 24 | $885.1M | $1.2B | ||
| Q3 24 | $901.9M | $1.2B | ||
| Q2 24 | $904.5M | $1.2B | ||
| Q1 24 | $831.9M | $1.1B |
负债/权益比APLSOXM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.35× | 0.05× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $-9.1M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $-47.9M |
| 自由现金流率自由现金流/营收 | -7.1% | -15.6% |
| 资本支出强度资本支出/营收 | 0.1% | 12.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $45.0M | $-79.9M |
8季度趋势，按日历期对齐
经营现金流APLSOXM
| Q4 25 | $-14.2M | $-9.1M | ||
| Q3 25 | $108.5M | $83.5M | ||
| Q2 25 | $4.4M | $-3.9M | ||
| Q1 25 | $-53.4M | — | ||
| Q4 24 | $19.4M | $-18.2M | ||
| Q3 24 | $34.1M | $88.8M | ||
| Q2 24 | $-8.3M | $32.9M | ||
| Q1 24 | $-133.0M | $74.9M |
自由现金流APLSOXM
| Q4 25 | $-14.3M | $-47.9M | ||
| Q3 25 | $108.3M | $52.3M | ||
| Q2 25 | $4.4M | $-27.4M | ||
| Q1 25 | $-53.4M | — | ||
| Q4 24 | $19.3M | $-56.9M | ||
| Q3 24 | — | $47.2M | ||
| Q2 24 | $-8.4M | $21.0M | ||
| Q1 24 | $-133.3M | $55.3M |
自由现金流率APLSOXM
| Q4 25 | -7.1% | -15.6% | ||
| Q3 25 | 23.6% | 13.0% | ||
| Q2 25 | 2.5% | -7.0% | ||
| Q1 25 | -32.0% | — | ||
| Q4 24 | 9.1% | -18.5% | ||
| Q3 24 | — | 11.2% | ||
| Q2 24 | -4.2% | 5.3% | ||
| Q1 24 | -77.3% | 13.7% |
资本支出强度APLSOXM
| Q4 25 | 0.1% | 12.6% | ||
| Q3 25 | 0.0% | 7.7% | ||
| Q2 25 | 0.0% | 6.0% | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.0% | 12.6% | ||
| Q3 24 | 0.0% | 9.9% | ||
| Q2 24 | 0.0% | 3.0% | ||
| Q1 24 | 0.2% | 4.8% |
现金转化率APLSOXM
| Q4 25 | — | — | ||
| Q3 25 | 0.50× | 5.00× | ||
| Q2 25 | — | -0.15× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.19× | ||
| Q2 24 | — | 0.86× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
OXM
| Sales Channel Retail | $162.9M | 53% |
| Sales Channel Wholesale | $61.3M | 20% |
| Johnny Was | $45.4M | 15% |
| Sales Channel Food And Beverage | $29.3M | 10% |
| Other Foreign Countries | $9.0M | 3% |
